Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$209.01 - $232.56 $7,315 - $8,139
-35 Reduced 4.17%
805 $176,000
Q4 2023

Feb 09, 2024

BUY
$197.69 - $227.29 $66,819 - $76,824
338 Added 67.33%
840 $191,000
Q3 2023

Nov 13, 2023

BUY
$201.05 - $221.7 $18,295 - $20,174
91 Added 22.14%
502 $101,000
Q2 2023

Aug 11, 2023

SELL
$211.93 - $241.33 $847 - $965
-4 Reduced 0.96%
411 $99,000
Q1 2023

May 15, 2023

SELL
$213.32 - $257.83 $5,546 - $6,703
-26 Reduced 5.9%
415 $95,000
Q4 2022

Feb 13, 2023

BUY
$203.72 - $248.97 $10,186 - $12,448
50 Added 12.79%
441 $103,000
Q3 2022

Nov 14, 2022

SELL
$204.81 - $262.19 $30,926 - $39,590
-151 Reduced 27.86%
391 $80,000
Q2 2022

Aug 10, 2022

SELL
$213.86 - $277.87 $14,970 - $19,450
-70 Reduced 11.44%
542 $127,000
Q1 2022

May 13, 2022

BUY
$259.82 - $298.18 $83,921 - $96,312
323 Added 111.76%
612 $162,000
Q4 2021

Feb 10, 2022

BUY
$271.6 - $314.21 $78,492 - $90,806
289 New
289 $91,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.9B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.